Research team
Expertise
Modelling and cost-effectiveness analyses of vaccination strategies against infectious diseases become my great interest and passion. I have more than 12 years of experience conducting health economics evaluations on several vaccines, including hepatitis B, human papillomavirus, rotavirus, pertussis, varicella and influenza. My previous professional experience includes: burden of disease studies, systematic literature reviews, cost-effectiveness and budget impact analyses, quality of life studies, dynamic transmission models, model compariosn, development of reimbursement dossiers, project management, and communication with various stakeholders. I am a member of RESCEU (REspiratory Syncytial virus Consortium in EUrope) and PROMISE (Preparing for RSV immunisation and surveillance in Europe). My primary research topic is the multi-country economic evaluations of interventions against RSV, influenza, and rotavirus.